SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (1)4/4/2001 11:48:38 PM
From: Miljenko Zuanic  Read Replies (3) of 1840
 
Spekulatious,

You also do not have OSIP or IMCL in your portfolio. Why?

EGF is one of the HOTEST new cancer target and both company (I do not believe to much in C225, but that is another story) deserve to be in portfolio. Also, ABGX (now in collaboration with IMNX) also have potent anti-EGFr antibody, now at the PI-end.

Some other cancer targets will emerge in next 12 months, but I will leave them for that time.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News